Product Reports Resources Pricing Login Book a demo

Mnemo Therapeutics

Biotech & Life Sciences · Paris, France · Founded 2019

Developing powerful cell therapies that create accessible cures for solid tumors and blood cancers. EnfiniT platform, a groundbreaking drug discovery engine MoreLess

MNEMO specializes in providing robust data protection solutions that ensure compliance with global privacy regulations, including the General Data Protection Regulation (GDPR) and the French Data Protection Act. The company serves a diverse range of clients, including businesses and organizations that handle sensitive personal data and require stringent data security measures. Operating primarily in the data protection and cybersecurity market, MNEMO's business model focuses on offering tailored solutions that safeguard personal data against breaches and unauthorized access. The company generates revenue through subscription-based services, consulting fees, and implementation of data protection frameworks. MNEMO's services are designed to meet the specific needs of clients, ensuring that their data management practices align with legal requirements and industry standards. The company also leverages advanced analytics tools, such as Google Analytics, to enhance its service offerings and provide clients with actionable insights. Additionally, MNEMO maintains a global presence with affiliates in New York, ensuring that it can support clients with international data transfer needs while adhering to applicable regulations.

Keywords: data protection, GDPR compliance, cybersecurity, personal data, privacy regulations, data security, consulting services, global presence, analytics, legal compliance.

Company overview

Mnemo Therapeutics company information

The essential company record, classifications and operating signals in one place.

Status
Low Activity
Founded
2019
Headquarters
Paris, France
Employees
11
Open positions
None listed
Dealroom signal
0.0
client focusb2bsub industryPharmaceuticalsub industryBioTechnologybusiness modelManufacturingindustryHealthsectorBiotechnologysectorOncologysectorDrug DevelopmentsectorSpinoutsectorBiotech and PharmasectorAI Drug Discoverysectorbiotech medtech and e-healthsectorObservatoire DeeptechsectorTechbio

Valuation & funding

Mnemo Therapeutics funding history

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES AOther financing Jun 2021 $83M $330M Casdin Capital · Redmile Group · Alexandria Venture Investments · Emerson Collective
SEEDOther financing Dec 2020 $0 Casdin Capital
SPINOUTOther financing Jan 2019 $0 PSL University · Institut Curie
Showing 3 recorded eventsUnlock the complete deal history →

Financials

Workforce over time

Available workforce history. Financial fields without reported data are omitted.

YearEmployees
2026 11
2025 17
2024 32
2023 44
2022 60
2021 27
Company filings, research estimates and Dealroom dataOpen the full financial model →

Growth signals

Mnemo Therapeutics website traffic

Latest recorded traffic for Mnemo Therapeutics is 240 monthly website visits, down 68.8% over the last three months. Mnemo Therapeutics's team declined 35.3% over the past year.

Latest monthly visits240 3-month web change-68.8% 1-year team growth-35.3%
Monthly website visits34 observations · Jan 2022–Oct 2025
Hover or focus a point to see its exact monthly valueCompare with peers →

Comparisons

Mnemo Therapeutics compared with similar companies

Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.

Showing 8 of the closest matchesCompare every metric →

Talent graph

Mnemo Therapeutics's talent

Book a demo to see the people
Team profiled 7 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 5 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

7 investors on Mnemo Therapeutics's cap table

Sourced from Dealroom's funding and investor records. Investor profile links are shown where available.

Seed 1 investor entered at this stage
Series A 4 investors entered at this stage
Sofinnova Partners
Redmile Group
Alexandria Venture Investments
Emerson Collective
Other known 2 additional known investors
Institut Curie
PSL University

Global footprint

Where Mnemo Therapeutics has talent and traffic

Workforce by country
2 countries with
team presence
🇫🇷 France87.5%
🇺🇸 United States12.5%
2 countries shown

In the news

Latest news about Mnemo Therapeutics

Recent press, funding announcements, and product moves mentioning Mnemo Therapeutics — open to read from the original sources.

See all news

Market sentiment

What the market is saying about Mnemo Therapeutics

An AI-synthesized read of the highest-engagement posts about Mnemo Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Mnemo Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.